Чтение онлайн

30.Johnston IDA, Prescott RJ, Chalmers JC, et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 1997; 52: 38-44.

31.Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18: 136-147.

32.Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-1315.

33.Katzenstein AL, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986; 10: 256-267.

34.Katzenstein AL, Zisman DA, Litzky LA, et al. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002; 26: 1567-1577.

35.Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby Т. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006; 27:143-150.

36.King Jr TE, Tooze JA, Schwarz MI, Brown KR, Cheriack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164: 1171- 81.

37.Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathological findings in three cases. Chest 1993; 103: 1808 - 1812.

38.Lama VN, Flaherty KR, TowesGB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003; 168: 1084-90.

39.Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am J Respir Crit Care Med 2000; 162: 571 - 577.

40.Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965; 39: 369 - 404.

41.Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973; 57: 809-843.

42.Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010-1019.

43.Nagai S, Kitaichi M, Izumi T. Classification and recent advances in idiopathic interstitial pneumonia. Curr Opin Pulm Med 1998; 4: 256-260.

44.Nicholson AG. Classification of idiopathic interstitial pneumonias: making sense of the alphabet soup. Histopathology 2002; 41: 381-391.

45.Nicholson AG, Colby TV, Wells AU. Histopathological approach to patterns of interstitial pneumonia in patient with connective tissue disorders. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 10-17.

46.Olson J, Colby TV, Elliott CG. Hamman-Rich syndrome revisited. Mayo Clin Proc 1990; 65:1538-1548.

47.Quefatieh A, Stone CH, Digiovine B, Toews GB, Hyzy RC. Low hospital mortality in patients with acute interstitial pneumonia. Chest 2003; 124: 554-559.

48.Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective, double-blind randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991; 144: 291-296.

49.Raghu G, Johnson WC, Lockhart D, et al. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label phase II study. Am J Respir Crit Care Med 1999; 159: 1061-1069.

50. Raghu G, Mageto YN, Lockhart D, et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease. A prospective study. Chest 1998; 116: 1168- 1174.

51.Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005; 127: 178 - 184.

52.Schwartz DA, Van Fossen DS, Davis CS, et al. Determinants of progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: 444-449

53.Selman M, Carrillo G, Salas J, et al.Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 1998; 114: 507-512.

54.Selman M, King Jr TE, Pardo A: Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implication for therapy. Ann Intern Med 2001; 134:136-151.

55.Vourlekis JS, Brown KK, Cool CD, Young DA, Cherniack RM, King TE Jr,, Schwarz MI. Acute interstitial pneumonitis. Case series and review of the literature. Medicine (Baltimore) 2000; 79: 369-378.

56.Watanabe K, Higuchi K, Ninomiya K, et al. Steroid treatment based on the findings of transbronchial biopsy in idiopathic interstitial pneumonia. Eur Respir J 2002; 20: 1213-1219.

57.Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64: 1373 - 1380

58.Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264-1269.

document:

$pr:

version: 01-2007.1

codepage: windows-1251

type: klinrek

id: kli57158322

: 11.2. ПОРАЖЕНИЯ ОРГАНОВ ДЫХАНИЯ ПРИ СИСТЕМНЫХ ЗАБОЛЕВАНИЯХ СОЕДИНИТЕЛЬНОЙ ТКАНИ

meta:

author:

fio[ru]: Л.П. Ананьева, А.В. Волков, А.В. Смирнов, О.А. Антелава

codes:

next:

type: dklinrek

code: III.VI

type: dkli00023

ВВЕДЕНИЕ

Системные заболевания соединительной ткани (СЗСТ) - группа воспалительных аутоиммунных заболеваний с частым вовлечением дыхательной системы. К самым частым и наиболее ярким представителям этой группы болезней относят ревматоидный артрит (РА), системную красную волчанку (СКВ), системную склеродермию (СС) и полимиозит/дерматомиозит (ПМ/ДМ). Реже встречаются смешанное заболевание соединительной ткани и болезнь Шегрена. Причины возникновения этих болезней неизвестны. В процесс могут вовлекаться все отделы респираторной системы: дыхательные пути, плевра, паренхима легких, мышцы, участвующие в акте дыхания, скелет грудной клетки и легочные сосуды [1, 2]. Разные СЗСТ могут иметь схожие проявления легочной патологии, и наоборот, одно заболевание может иметь несколько легочных проявлений.